Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D H Johnson

Showing results (41-50 of 376) with videos related to

Pageof 38
Sort By:
Seminars in Oncology|June 1, 1996
Ifosfamide in non-small cell lung cancerD H Johnson
Journal of the National Cancer Institute|September 4, 1996
Combined-modality therapy for unresectable, stage III non-small-cell lung cancer--caveat emptor or caveat venditor?D H Johnson
Seminars in Oncology|August 1, 1997
Small cell lung cancer in the elderly patientD H Johnson
Molecular & General Genetics : MGG|April 1, 1993
Adenine phosphoribosyltransferase genes in two Drosophila species: dosage compensation, a nuclear matrix attachment site, and a novel intron positionD H Johnson
Respiration Physiology|July 1, 1990
Vasodilators do not abolish pulmonary vascular critical closing pressureI Mayers, D H Johnson
Current Oncology Reports|December 21, 2000
Postoperative radiotherapy in resected non-small-cell lung cancer: every creek has two banksD H Johnson, A Turrisi
Hematology/Oncology Clinics of North America|December 1, 1991
Staging and prognostic factors in nonseminomatous testicular cancerP Murphy, D H Johnson
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|January 1, 1997
Trabecular meshwork phagocytosis in glaucomatous eyesY Matsumoto, D H Johnson
Journal of the National Cancer Institute|May 4, 1994
Chemotherapy for resectable stage III non-small-cell lung cancer--can that dog hunt?D H Johnson, S Piantadosi
Journal of Glaucoma|October 1, 1996
Enzymes protective of oxidative damage present in all decades of life in the trabecular meshwork, as detected by two-dimensional gel electrophoresis protein mapsP Russell, D H Johnson
Pageof 38

Showing results (41-50 of 376) with videos related to

Sort By:
Pageof 38
Seminars in Oncology|June 1, 1996
Ifosfamide in non-small cell lung cancerD H Johnson
Journal of the National Cancer Institute|September 4, 1996
Combined-modality therapy for unresectable, stage III non-small-cell lung cancer--caveat emptor or caveat venditor?D H Johnson
Seminars in Oncology|August 1, 1997
Small cell lung cancer in the elderly patientD H Johnson
Molecular & General Genetics : MGG|April 1, 1993
Adenine phosphoribosyltransferase genes in two Drosophila species: dosage compensation, a nuclear matrix attachment site, and a novel intron positionD H Johnson
Respiration Physiology|July 1, 1990
Vasodilators do not abolish pulmonary vascular critical closing pressureI Mayers, D H Johnson
Current Oncology Reports|December 21, 2000
Postoperative radiotherapy in resected non-small-cell lung cancer: every creek has two banksD H Johnson, A Turrisi
Hematology/Oncology Clinics of North America|December 1, 1991
Staging and prognostic factors in nonseminomatous testicular cancerP Murphy, D H Johnson
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|January 1, 1997
Trabecular meshwork phagocytosis in glaucomatous eyesY Matsumoto, D H Johnson
Journal of the National Cancer Institute|May 4, 1994
Chemotherapy for resectable stage III non-small-cell lung cancer--can that dog hunt?D H Johnson, S Piantadosi
Journal of Glaucoma|October 1, 1996
Enzymes protective of oxidative damage present in all decades of life in the trabecular meshwork, as detected by two-dimensional gel electrophoresis protein mapsP Russell, D H Johnson
Pageof 38